Stephen Hess: One of the really interesting things about Caza Health is that you’re focused on women’s health and diagnostics for that. Can you expand on what you’re doing to address women’s health?
Peggy Robinson: Caza’s really focused on diagnostics because women need better diagnostics.
As we started Caza, my business partner, Kent Murphy, and I took a look at what was going on in women’s health and there are on average 10 million cases for vaginosis. And yet, we have some molecular tests that are send-outs and in-office testing is wet-mount microscopy. So physicians are having to diagnose off the symptomatology or wet-mount microscopy, or they’re sending out a test. And if you have a vaginal infection, having to wait for your results is not something you want to do – you’d like immediate results back. And so, we have a Point of Care system that we’re using.
We also looked at spontaneous preterm birth because believe it or not, in this country, about 10 percent of preterm births are spontaneous. We spend $26 billion a year on preterm birth. About $18 billion of that is spent in the first year of a child’s life. And if we can keep that baby in utero for a couple more weeks, we can decrease the amount of life-long illness that that child could potentially have by staying in utero.
We have an assay that we’re in the process of developing for preterm birth to give a risk stratification for women and get them to have better information so they can either do something proactively or can prepare for the fact that their child may be preterm.
Stephen Hess: It’s amazing, the benefit that this diagnostic will provide for early term births. Peggy, if people want to get in touch with you or learn more about Caza, where can they find you?
Peggy Robinson: cazahealth.com and Caza has a LinkedIn profile that you can reach out to us on too.
Stephen Hess: And finally, for 2021 – I know we’re a third of the way through – but what one word or phrase would you use to describe your outlook for this year?
Peggy Robinson: Exciting. It is really an exciting time. In a blink of an eye, we are here in April, and I think in another blink of an eye, we will be coming into the summer. It’s an exciting time for us at Caza; we’re looking forward to finishing up that vaginosis assay and getting it out there in the research market.
Stephen Hess: That’s the Tea. Peggy, thank you so much for joining me today. It’s been a pleasure, as always, getting the chance to speak with you and to hear your unique insights, I really appreciate it.
It’s great hearing how your diagnostics is going to be helping so many women out there, and the technology is a platform for other women’s health issues as well.
So, thanks Peggy for joining me.
Peggy Robinson: Thank you, Steph. Always a pleasure to talk to you.
For more information about Caza Health, visit cazahealth.com or follow Caza Health on LinkedIn.